Key result
ARVC-iPSC-CMs carrying a novel OBSCN mutation exhibited significant accumulation of lipids (38.44% vs 8.58%, P=3.42e-05) and increased L-type calcium currents compared to control cells.
Answers are grounded in this paper and cite their sources.
OBSCN modulation may attenuate ARVC progression; hypothesis-generating and requires prospective validation before clinical consideration.
caused phenotypic alteration accompanied by disrupted localization and decreased expression of its anchoring protein Ank1.5. Furthermore, there was an accumulation of lipids with an increase in fatty fibrosis area and myocardial structural disorder, possibly leading to dysrhythmia in calcium channel-related myocardial contraction. These observations suggested the possibility of attenuating ARVC progression by therapeutic modulation of OBSCN expression.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2020) studied Arrhythmogenic right ventricular cardiomyopathy. OBSCN mutation vs. Control iPSC-CMs was evaluated on Positive staining for Oil Red O (lipid accumulation) (p=3.42e-05). ARVC-iPSC-CMs carrying a novel OBSCN mutation exhibited significant accumulation of lipids (38.44% vs 8.58%, P=3.42e-05) and increased L-type calcium currents compared to control cells.
Synapse has enriched 10 related papers. Consider them for comparative context: